Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

NCT05816785 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG: Cetuximab
DRUG: Imatinib

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]